Latest News by Industry
BOSTON (AP) — BOSTON (AP) — Ironwood Pharmaceuticals Inc. (IRWD) on Thursday reported fourth-quarter profit of $48.9 million.
The Boston-based company said it had net income of 27 cents per share.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 28 cents per share.
The drugmaker posted revenue of $107.2 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $110.7 million.
For the year, the company reported profit of $175.1 million, or 96 cents per share. Revenue was reported as $410.6 million.
Ironwood expects full-year revenue in the range of $420 million to $435 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a IRWD">Zacks stock report on IRWD at https://www.zacks.com/ap/IRWD